Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome

Clinical Journal of Oncology Nursing
Margaret F Bevans, Reem A Shalabi

Abstract

Antithymocyte globulin (ATG) is used commonly in patients with severe aplastic anemia and those undergoing renal transplant. Its utility also is being explored in the treatment of myelodysplastic syndrome, conditioning regimens for hematopoietic stem cell transplant, and prophylaxis of graft-versus-host disease. As indications for ATG expand, knowledge regarding its administration and management of associated toxicities is needed. These toxicities range from life-threatening anaphylaxis associated with the infusion to flu-like symptoms that occur one to two weeks after the infusion. Adverse effects are classified according to the severity and system impacted. Mild toxicities respond to comfort measures and include fever, chills, urticarial rash, and vomiting. Moderate toxicities require acute interventions and include fluid-responsive hypotension, nonischemic chest pain, and reversible oxygen desaturation. Severe toxicities require intensive support and include those refractory to earlier intervention. Management of these toxicities usually is limited to fluid resuscitation and noninvasive monitoring. Occurrence of infusion-related toxicities may require premature discontinuation of therapy. Therefore, an educated healthcare te...Continue Reading

References

Sep 1, 1987·Chest·D K MurdockR Pifarre
Jan 20, 1983·The New England Journal of Medicine·R ChamplinR P Gale
Feb 1, 1997·Bone Marrow Transplantation·S B KillickE C Gordon-Smith
May 8, 1997·The New England Journal of Medicine·N S Young, J Maciejewski
Jun 30, 1998·Archives of Internal Medicine·G D Walton, R J Gualtieri
Jun 12, 1999·Respiration; International Review of Thoracic Diseases·N MaillardP Camus
Jul 28, 1999·JAMA : the Journal of the American Medical Association·N S Young
Feb 17, 2000·Seminars in Hematology·N Frickhofen, S J Rosenfeld
Feb 25, 2000·Current Opinion in Oncology·R Dansey
Nov 4, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M M Millar, L C Grammer
Jan 5, 2002·Annals of Hematology·Y AsanoY Niho
Apr 3, 2002·Annals of Internal Medicine·Neal S Young
Jun 19, 2002·British Journal of Nursing : BJN·Brendan Docherty
Jul 20, 2002·British Journal of Nursing : BJN·Brendan Docherty
Aug 6, 2002·Annals of Internal Medicine·Jeffrey J MolldremA John Barrett
Sep 25, 2002·British Journal of Nursing : BJN·C Higgins
Jan 25, 2003·British Journal of Haematology·David BowenUNKNOWN UK MDS Guidelines Group
Feb 18, 2003·British Journal of Haematology·Sally B KillickJudith C W Marsh
Jul 2, 2003·Seminars in Oncology Nursing·Brenda K Shelton
Sep 27, 2003·British Journal of Nursing : BJN·Terry Ferns, Irena Chojnacka

❮ Previous
Next ❯

Citations

Feb 3, 2016·Frontiers in Immunology·Ana Luisa PerdigotoKevan C Herold
Jul 11, 2008·Immunological Reviews·Todd M BruskoJeffrey A Bluestone
Jan 22, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Esen DemirDeniz Yılmaz
Aug 29, 2006·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Mary Laudon Thomas
May 12, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Basset ElEssawy, Xian C Li
May 30, 2012·Clinical Journal of Oncology Nursing·Jean A RidgewayNuria Borràs
Aug 18, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Miranda Hall, Tracy M Hagemann
Sep 24, 2013·Research and Theory for Nursing Practice·Irene Oliveira
Dec 30, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Tiene BautersGeneviève Laureys
Mar 3, 2015·Allergy & Rhinology·Stephanie A WolaninEric A Meier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.